You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Friday, May 17, 2024 | 4:45 PM EST
admIRE Study Late-Breaker
admIRE Study Late-Breaker
Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the Biosense Webster IRE Ablation System
Championing Diversity in EP
Championing Diversity in EP
As a global leader in the science of diagnosing and treating heart rhythm disorders, Biosense Webster is uniquely positioned to support the EP community. Our programs and collaborations aim to foster diversity, encourage connections and fuel the next generation of EPs.